Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens

Burkitt lymphoma is an aggressive B cell malignancy accounting for 1–2% of all adult lymphomas. Treatment with dose-intensive, multi-agent chemotherapy is effective but associated with considerable toxicity. In this observational study, we compared real-world efficacy, toxicity, and costs of four fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Oosten, L. E. M., Chamuleau, M. E. D., Thielen, F. W., de Wreede, L. C., Siemes, C., Doorduijn, J. K., Smeekes, O. S., Kersten, M. J., Hardi, L., Baars, J. W., Demandt, A. M. P., Stevens, W. B. C., Nijland, M., van Imhoff, G. W., Brouwer, R., Uyl-de Groot, C. A., Kluin, P. M., de Jong, D., Veelken, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754407/
https://www.ncbi.nlm.nih.gov/pubmed/29209924
http://dx.doi.org/10.1007/s00277-017-3167-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754407/
https://www.ncbi.nlm.nih.gov/pubmed/29209924
http://dx.doi.org/10.1007/s00277-017-3167-7

Ejemplares similares